Back

Salarius Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference

Read More

Back

Salarius Pharmaceuticals Reports Business Highlights with First Quarter 2022 Financial Results

Read More

Back

Salarius Pharmaceuticals Completes SP-3164 Pre-Investigational New Drug Meeting Process with the U.S. Food and Drug Administration

Read More

Back

Salarius Pharmaceuticals to Report First Quarter 2022 Financial Results and Highlight Recent Company Progress

Read More